CLNN Insider Transactions
Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
---|---|---|---|---|---|---|---|---|
2023-02-17 | Mortenson Mark | 75,000 | A-Award | A | 75,000 | 1.28 | 96,000.00 | |
2023-02-17 | BROWN MORGAN R | 125,000 | A-Award | A | 125,000 | 1.28 | 160,000.00 | |
2022-12-31 | Ugwumba Chidozie | director: | 0 | 0 | 0.00 | 0.00 | ||
2023-02-02 | Jacobovitz Shalom | 12,124 | A-Award | A | 12,124 | 1.62 | 19,640.88 | |
2023-02-02 | McLaughlin Vallerie | 8,966 | A-Award | A | 8,966 | 1.62 | 14,524.92 | |
2023-02-02 | MATLIN DAVID J | 15,894 | A-Award | A | 15,894 | 1.62 | 25,748.28 | |
2023-02-02 | Ugwumba Chidozie | 9,679 | A-Award | A | 9,679 | 1.62 | 15,679.98 | |
2023-02-02 | Gay Jonathon | 8,966 | A-Award | A | 8,966 | 1.62 | 14,524.92 | |
2023-02-02 | Mosca Alison | 12,430 | A-Award | A | 12,430 | 1.62 | 20,136.60 | |
2023-02-02 | Stevens John Henry | 9,373 | A-Award | A | 9,373 | 1.62 | 15,184.26 | |
2022-11-14 | WILCOX REED N | director | 575,145 | M-Exempt | A | 174,912 | 0.15 | 26,236.80 |
2022-11-14 | WILCOX REED N | director | 0 | M-Exempt | A | 174,912 | 0.00 | 0.00 |
2022-11-04 | Mortenson Mark | director: Chief Science Officer | 400,000 | A-Award | A | 400,000 | 0.00 | 0.00 |
2022-11-04 | BROWN MORGAN R | director: Chief Financial Officer | 300,000 | A-Award | A | 300,000 | 0.00 | 0.00 |
2022-11-04 | Etherington Robert Dee | director: Chief Executive Officer | 400,000 | A-Award | A | 400,000 | 0.00 | 0.00 |
2022-11-03 | Jacobovitz Shalom | director | 16,382 | A-Award | A | 16,382 | 0.00 | 0.00 |
2022-11-03 | Mosca Alison | director | 16,795 | A-Award | A | 16,795 | 0.00 | 0.00 |
2022-11-03 | MATLIN DAVID J | director | 21,476 | A-Award | A | 21,476 | 0.00 | 0.00 |
2022-11-03 | Gay Jonathon | director | 12,115 | A-Award | A | 12,115 | 0.00 | 0.00 |
2022-11-03 | Ugwumba Chidozie | director | 13,078 | A-Award | A | 13,078 | 0.00 | 0.00 |
2022-11-03 | Stevens John Henry | director | 12,665 | A-Award | A | 12,665 | 0.00 | 0.00 |
2022-11-03 | McLaughlin Vallerie | director | 12,115 | A-Award | A | 12,115 | 0.00 | 0.00 |
2022-11-02 | MATLIN DAVID J | director | 5,293,684 | P-Purchase | A | 2,871,287 | 1.01 | 2,899,999.87 |
2022-11-02 | Gay Jonathon | director | 2,154,848 | P-Purchase | A | 990,099 | 1.01 | 999,999.99 |
2022-11-02 | Ugwumba Chidozie | director | 5,518,908 | P-Purchase | A | 990,099 | 1.01 | 999,999.99 |
2022-11-02 | Mosca Alison | director | 844,000 | P-Purchase | A | 792,079 | 1.01 | 799,999.79 |
2022-11-02 | Stevens John Henry | director | 483,749 | P-Purchase | A | 148,515 | 1.01 | 150,000.15 |
2022-08-17 | Stevens John Henry | director: | 335,234 | P-Purchase | A | 47,662 | 3.85 | 183,498.70 |
2022-08-04 | Jacobovitz Shalom | director: | 5,124 | A-Award | A | 5,124 | 0.00 | 0.00 |
2022-08-04 | MATLIN DAVID J | director: | 6,717 | A-Award | A | 6,717 | 0.00 | 0.00 |
2022-08-04 | McLaughlin Vallerie | director: | 3,789 | A-Award | A | 3,789 | 0.00 | 0.00 |
2022-08-04 | Mosca Alison | director: | 5,253 | A-Award | A | 5,253 | 0.00 | 0.00 |
2022-08-04 | Stevens John Henry | director: | 3,961 | A-Award | A | 3,961 | 0.00 | 0.00 |
2022-08-04 | Ugwumba Chidozie | director: | 4,090 | A-Award | A | 4,090 | 0.00 | 0.00 |
2022-07-18 | Etherington Robert Dee | director: Chief Executive Officer | 56,593 | S-Sale | D | 23,483 | 4.72 | 110,839.76 |
2022-06-16 | MATLIN DAVID J | director: | 2,422,397 | P-Purchase | A | 74,610 | 2.51 | 187,271.10 |
2022-06-16 | Mortenson Mark | director: Chief Science Officer | 168,759 | S-Sale | D | 20,247 | 2.47 | 50,010.09 |
2022-06-15 | Mosca Alison | director: | 39,476 | P-Purchase | A | 5,000 | 2.62 | 13,100.00 |
2022-06-14 | MATLIN DAVID J | director: | 2,272,787 | P-Purchase | A | 45,000 | 2.66 | 119,700.00 |
2022-06-13 | MATLIN DAVID J | director: | 2,176,776 | P-Purchase | A | 55,000 | 3.06 | 168,300.00 |
2022-06-03 | MATLIN DAVID J | director: | 2,071,106 | P-Purchase | A | 10,000 | 2.46 | 24,600.00 |
2022-05-27 | MATLIN DAVID J | director: | 2,061,106 | P-Purchase | A | 35,000 | 2.27 | 79,450.00 |
2022-05-16 | General Resonance LLC | director: | 15,560,212 | S-Sale | D | 181,818 | 2.20 | 399,999.60 |
2022-05-16 | MATLIN DAVID J | director: | 2,026,106 | P-Purchase | A | 181,818 | 2.20 | 399,999.60 |
2022-05-16 | Glanzman Robert | director: Chief Medical Officer | 10,564 | S-Sale | D | 4,717 | 2.03 | 9,575.51 |
2022-05-16 | Gay Jonathon | director: | 68,745 | P-Purchase | A | 10,000 | 2.08 | 20,800.00 |
2022-05-05 | Gay Jonathon | director: | 5,032 | A-Award | A | 5,032 | 0.00 | 0.00 |
2022-05-05 | Mosca Alison | director: | 6,976 | A-Award | A | 6,976 | 0.00 | 0.00 |
2022-05-05 | Ugwumba Chidozie | director: | 5,432 | A-Award | A | 5,432 | 0.00 | 0.00 |
2022-05-05 | Stevens John Henry | director: | 5,261 | A-Award | A | 5,261 | 0.00 | 0.00 |
2022-05-05 | McLaughlin Vallerie | director: | 30,000 | A-Award | A | 30,000 | 0.00 | 0.00 |
2022-05-05 | MATLIN DAVID J | director: | 30,000 | A-Award | A | 30,000 | 0.00 | 0.00 |
2022-05-05 | Jacobovitz Shalom | director: | 30,000 | A-Award | A | 30,000 | 0.00 | 0.00 |
2022-05-02 | WILCOX REED N | director: | 174,912 | M-Exempt | D | 100,000 | 0.00 | 0.00 |
2022-04-21 | General Resonance LLC | director: | 15,742,030 | S-Sale | D | 132,891 | 3.01 | 400,001.91 |
2022-04-20 | MATLIN DAVID J | director: | 1,844,288 | P-Purchase | A | 132,891 | 3.01 | 400,001.91 |
2022-03-28 | MATLIN DAVID J | director: | 1,711,397 | P-Purchase | A | 8,648 | 3.23 | 27,933.04 |
2022-03-23 | MATLIN DAVID J | director: | 1,672,749 | P-Purchase | A | 20,000 | 2.94 | 58,800.00 |
2022-03-18 | MATLIN DAVID J | director: | 1,652,749 | P-Purchase | A | 35,000 | 2.90 | 101,500.00 |
2021-12-31 | Ugwumba Chidozie | director | 4,528,809 | J-Other | A | 4,528,809 | 0.00 | 0.00 |
2022-02-17 | Stevens John Henry | 287,572 | M-Exempt | A | 273,194 | 0.53 | 144,792.82 | |
2022-02-17 | Stevens John Henry | 0 | M-Exempt | D | 273,194 | 0.53 | 144,792.82 | |
2022-02-15 | Mortenson Mark | 200,000 | A-Award | A | 200,000 | 3.04 | 608,000.00 | |
2022-02-15 | Glanzman Robert | 140,000 | A-Award | A | 140,000 | 3.04 | 425,600.00 | |
2022-02-15 | Etherington Robert Dee | 69,652 | A-Award | A | 69,652 | 3.04 | 211,742.08 | |
2022-02-15 | Etherington Robert Dee | 480,000 | A-Award | A | 480,000 | 3.04 | 1,459,200.00 | |
2022-02-03 | Stevens John Henry | 5,721 | A-Award | A | 5,721 | 2.71 | 15,503.91 | |
2022-02-03 | Ugwumba Chidozie | 5.908 | A-Award | A | 5.908 | 2.71 | 16.01 | |
2022-02-03 | Stevens John Henry | 6,219 | A-Award | A | 6,219 | 2.71 | 16,853.49 | |
2022-02-03 | Mosca Alison | 7,587 | A-Award | A | 7,587 | 2.71 | 20,560.77 | |
2022-02-03 | McLaughlin Vallerie | 5,473 | A-Award | A | 5,473 | 2.71 | 14,831.83 | |
2022-02-03 | MATLIN DAVID J | 9,701 | A-Award | A | 9,701 | 2.71 | 26,289.71 | |
2022-02-03 | Jacobovitz Shalom | 7,400 | A-Award | A | 7,400 | 2.71 | 20,054.00 | |
2022-02-03 | Gay Jonathon | 5,473 | A-Award | A | 5,473 | 2.71 | 14,831.83 | |
2022-02-01 | BROWN MORGAN R | 0 | D | 0 | 0.00 | 0.00 | ||
2022-02-01 | General Resonance LLC | 10 percent owner | 15,874,921 | S-Sale | D | 101,352 | 2.96 | 300,001.92 |
2022-02-01 | BROWN MORGAN R | 250,000 | A-Award | A | 250,000 | 2.96 | 740,000.00 | |
2022-02-01 | MATLIN DAVID J | 1,597,749 | P-Purchase | A | 101,352 | 2.96 | 300,001.92 | |
2022-01-20 | WILCOX REED N | 300,233 | M-Exempt | A | 253,000 | 0.15 | 37,950.00 | |
2022-01-20 | WILCOX REED N | 274,911 | M-Exempt | D | 253,000 | 0.15 | 37,950.00 | |
2021-10-01 | Mosca Alison | director | 3,006,670 | X-InTheMoney | A | 15,000 | 0.01 | 150.00 |
2021-10-01 | Mosca Alison | director | 1,459,945 | X-InTheMoney | A | 10,000 | 0.01 | 100.00 |
2021-10-01 | Mosca Alison | director | 0 | X-InTheMoney | D | 10,000 | 0.01 | 100.00 |
2021-12-08 | MATLIN DAVID J | 1,441,397 | P-Purchase | A | 5,000 | 4.93 | 24,650.00 | |
2021-12-09 | MATLIN DAVID J | 1,481,397 | P-Purchase | A | 40,000 | 5.00 | 200,000.00 | |
2021-12-10 | MATLIN DAVID J | 1,496,397 | P-Purchase | A | 15,000 | 4.87 | 73,050.00 | |
2021-12-06 | MATLIN DAVID J | 1,436,397 | X-InTheMoney | A | 12,500 | 0.01 | 125.00 | |
2021-12-06 | MATLIN DAVID J | 150,000 | X-InTheMoney | A | 50,000 | 0.01 | 500.00 | |
2021-12-06 | MATLIN DAVID J | 0 | X-InTheMoney | D | 50,000 | 0.01 | 500.00 | |
2021-11-16 | MATLIN DAVID J | 1,423,897 | P-Purchase | A | 20,000 | 5.26 | 105,200.00 | |
2021-11-12 | MATLIN DAVID J | 1,388,897 | P-Purchase | A | 10,000 | 5.37 | 53,700.00 | |
2021-11-15 | MATLIN DAVID J | 1,403,897 | P-Purchase | A | 15,000 | 5.71 | 85,650.00 | |
2021-11-04 | Ugwumba Chidozie | 3,441 | A-Award | A | 3,441 | 4.74 | 16,310.34 | |
2021-11-04 | Mortenson Mark | 200,000 | A-Award | A | 200,000 | 4.74 | 948,000.00 | |
2021-11-04 | Mosca Alison | 4,419 | A-Award | A | 4,419 | 4.74 | 20,946.06 | |
2021-11-04 | Jeong Tae Heum | 62,500 | A-Award | A | 62,500 | 4.74 | 296,250.00 | |
2021-11-04 | Etherington Robert Dee | 100,000 | A-Award | A | 100,000 | 4.74 | 474,000.00 | |
2021-11-04 | Glanzman Robert | 100,000 | A-Award | A | 100,000 | 4.74 | 474,000.00 | |
2021-11-04 | Stevens John Henry | 3,333 | A-Award | A | 3,333 | 4.74 | 15,798.42 | |
2021-11-04 | McLaughlin Vallerie | 3,188 | A-Award | A | 3,188 | 4.74 | 15,111.12 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.